X-115190093-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001145346.2(RBMXL3):c.652G>A(p.Gly218Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000133 in 1,154,111 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 45 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145346.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBMXL3 | NM_001145346.2 | c.652G>A | p.Gly218Ser | missense_variant | 1/1 | ENST00000424776.5 | NP_001138818.1 | |
LRCH2 | NM_020871.4 | c.350-1723C>T | intron_variant | ENST00000317135.13 | NP_065922.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBMXL3 | ENST00000424776.5 | c.652G>A | p.Gly218Ser | missense_variant | 1/1 | 6 | NM_001145346.2 | ENSP00000417451.3 | ||
LRCH2 | ENST00000317135.13 | c.350-1723C>T | intron_variant | 1 | NM_020871.4 | ENSP00000325091.8 | ||||
LRCH2 | ENST00000538422.2 | c.350-1723C>T | intron_variant | 1 | ENSP00000439366.1 |
Frequencies
GnomAD3 genomes AF: 0.000433 AC: 49AN: 113223Hom.: 0 Cov.: 26 AF XY: 0.000339 AC XY: 12AN XY: 35363
GnomAD3 exomes AF: 0.000279 AC: 27AN: 96892Hom.: 0 AF XY: 0.000196 AC XY: 6AN XY: 30552
GnomAD4 exome AF: 0.000102 AC: 106AN: 1040838Hom.: 0 Cov.: 35 AF XY: 0.000101 AC XY: 34AN XY: 335372
GnomAD4 genome AF: 0.000424 AC: 48AN: 113273Hom.: 0 Cov.: 26 AF XY: 0.000311 AC XY: 11AN XY: 35423
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.652G>A (p.G218S) alteration is located in exon 1 (coding exon 1) of the RBMXL3 gene. This alteration results from a G to A substitution at nucleotide position 652, causing the glycine (G) at amino acid position 218 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at